Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Structured Neuromuscular Exercise Program (nmep-run)

12. mai 2026 oppdatert av: Elif Tunç

The Effect of s Structured Neuromuscular Exercise Program on Running Performance and Lower Extremity Biomechanics in Recreational Runners

This randomized controlled trial aims to investigate the effects of an 8-week structured neuromuscular exercise program on running performance and lower extremity biomechanics in recreational runners. The program includes progressive exercises focusing on hip and core strength, balance, plyometric control, and running-specific mobility. Participants will be randomly assigned to an intervention or control group. The intervention group will perform the neuromuscular training twice a week for eight weeks, while the control group will not receive any structured exercise. Pre- and post-intervention assessments will include biomechanical analysis and functional performance tests. The study aims to provide evidence for the preventive and performance-enhancing benefits of neuromuscular training in runners.

Studieoversikt

Detaljert beskrivelse

Running is a repetitive and high-impact activity that places significant mechanical stress on the lower extremities. Improper movement patterns, muscle imbalances, and reduced neuromuscular control have been identified as key contributors to running-related injuries. Previous studies have demonstrated that neuromuscular training can enhance movement efficiency, improve joint stability, and reduce injury risk in athletic populations. However, there is limited evidence on the structured and progressive application of neuromuscular exercise programs specifically designed for recreational runners.

The present randomized controlled trial aims to evaluate the effects of an 8-week structured neuromuscular exercise program on running performance and lower extremity biomechanics in recreational runners. The intervention includes progressive exercises focusing on hip and core strength, dynamic balance, plyometric control, and running-specific mobility. Participants will be randomly assigned to either an intervention or control group. The intervention group will perform the neuromuscular training twice weekly under supervision, while the control group will maintain their usual physical activity routine. Biomechanical assessments and functional performance tests will be conducted before and after the intervention period. This study seeks to provide scientific evidence supporting the preventive and performance-enhancing benefits of neuromuscular training in runners, contributing to injury prevention and performance optimization strategies.

Studietype

Intervensjonell

Registrering (Antatt)

24

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Istanbul
      • Kadıköy, Istanbul, Tyrkia (Türkiye), 34726
        • PT Academy

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Age between 18 and 55 years

Recreational runners who have been running regularly (at least twice per week for the last 6 months)

No current musculoskeletal injury limiting running

Willing to participate in the 8-week neuromuscular exercise program and attend follow-up assessments

Able to provide informed consent

Exclusion Criteria:

  • History of lower limb surgery or fracture in the past 6 months

Neurological, vestibular, or systemic diseases affecting balance or gait

Current participation in a structured strength or neuromuscular training program

Pregnancy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: NEUROMUSCULAR EXERCISE GROUP
Participants in this group will not receive any structured exercise program during the 8-week intervention period. They will maintain their usual physical activity and running habits. Assessments will be performed at the same pre- and post-intervention time points as the intervention group.
An 8-week structured neuromuscular exercise program including progressive exercises targeting hip and core strength, dynamic balance, plyometric control, and running-specific mobility. The program is performed twice per week under supervision. It is designed to improve running performance, neuromuscular control, and lower limb biomechanics in recreational runners.
Ingen inngripen: CONTROL GROUP
Participants in this group will not receive any structured exercise program during the 8-week intervention period. They will maintain their usual physical activity and running habits. Assessments will be performed at the same pre- and post-intervention time points as the intervention group.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Running performance
Tidsramme: Baseline and after 8 weeks of intervention
Change in running performance will be assessed using a standardized time-trial test to evaluate the effectiveness of the neuromuscular exercise program in improving endurance and speed in recreational runners.
Baseline and after 8 weeks of intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dynamic balance
Tidsramme: Baseline and after 8 weeks of intervention
Balance performance will be evaluated using the Y-Balance Test to determine improvements in postural control after the neuromuscular training intervention.
Baseline and after 8 weeks of intervention
Lower limb strength
Tidsramme: Baseline and after 8 weeks of intervention
hip abductor muscle strength will be measured using handheld dynamometry
Baseline and after 8 weeks of intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. mai 2026

Primær fullføring (Antatt)

1. september 2026

Studiet fullført (Antatt)

1. september 2026

Datoer for studieregistrering

Først innsendt

1. januar 2026

Først innsendt som oppfylte QC-kriteriene

12. mai 2026

Først lagt ut (Faktiske)

19. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. mai 2026

Sist bekreftet

1. januar 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) will not be shared because the dataset includes identifiable physiological and biomechanical data collected from human participants. Data sharing is restricted by ethical approval and participant consent regulations. Only aggregated results will be reported in publications.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere